Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C Clifford

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Genes & Development|October 4, 2017
TAp73 is a marker of glutamine addiction in medulloblastomaMaria Victoria Niklison-Chirou, Ida Erngren, Mikael Engskog, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Nature Communications|April 13, 2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptationSara Badodi, Nicola Pomella, Xinyu Zhang, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
Communications Biology|October 17, 2020
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studyEdward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
Acta Neuropathologica|January 27, 2011
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsDavid W Ellison, James Dalton, Mehmet Kocak, et al.
Genes & Development|October 4, 2017
TAp73 is a marker of glutamine addiction in medulloblastomaMaria Victoria Niklison-Chirou, Ida Erngren, Mikael Engskog, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Nature Communications|April 13, 2021
Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptationSara Badodi, Nicola Pomella, Xinyu Zhang, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Epigenetics|August 4, 2015
Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemiaAlem S Gabriel, Fadhel M Lafta, Edward C Schwalbe, et al.
Communications Biology|October 17, 2020
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cellsManon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, et al.
Pageof 13